12
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Hepatitis C Virus Transmission, 1988–1991, via Blood Components from Donors Subsequently Found to be Anti-HCV-positive

, , , &
Pages 21-26 | Received 02 Feb 1995, Accepted 20 Oct 1995, Published online: 08 Jul 2009

References

  • Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood borne non-A, non-B hepatitis genome. Science 1989; 244: 359–361
  • Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell LH, Miyamura Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–364
  • Widell A, Månsson AS, Sundström G, Hansson B, Nordenfeldt E. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays. J Med Virol 1991; 35: 253–258
  • Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M. Typing hepatitis C virus by polymerase chain reaction with type specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673–679
  • Chan SW, Mc Omish F, Holmes Dow B, Peutherer JF, Follett E, Yap PL, Simmonds P. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73: 1131–1141
  • Widell A, Shev S, Månsson S, Zhang Y-Y, Foberg U, Norkrans G, Frydén A, Weiland O, Kurkus J, Nordenfelt E. Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: Epidemiological applications. J Med Virol 1994; 144: 272–279
  • Shev S, Widell A, Foberg U, Frydén A, Hermodsson S, Lindh G, Lindholm A, Månsson S, Weiland O, Norkrans G. HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile. Infection 1995; 23: 253–257
  • Mathiesen U, Ekermo B, Foberg U, Franzén A, Frydén A, Norlin R, Petterson L-G, Sterling A, Widell A, Bodemar G. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low risk areas. Scand J Gastroenterol 1992; 27: 443–448
  • Ayob Y, Davidson JI, Baxter A, Jordan A, Yap PL, Gillon J. Risk of hepatitis C in patients who received blood from donors subsequently shown to be carriers of hepatitis C virus. Transf Med 1994; 4: 269–272
  • Vrielink H, van der Poel CL, Reesink HW, Zaijer HL, Scholten E, Kremer L CM, Cuypers H TM, Lelie PN, van Oers M HJ. Look-back study of infectivity of anti-HCV ELISA positive blood components. Lancet 1995; 345: 95–96
  • Skaug K, Li H, Jonassen T, Larsen J, Figenschau KJ. Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients. Vox Sang 1993; 64: 215–219
  • Aoki SK, Holland PV, Fernando IK, Anderson S, Sazama K, Schoening V, Johnson P, Wilber JC, Fenner L, Alter HJ. Evidence of hepatitis in patients receiving transfusions of blood components containing antibody to hepatitis C. Blood 1993; 83(3)1000–1005
  • McGuinness PH, Bishop GA, Lien A, Wiley B, Parsons C, McCaughan GW. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors. Hepatology 1993; 18(3)485–490
  • Löve A, Smaradottir A, Thorsteinsson S, Stanzeit B, Widell A. Hepatitis C virus genotypes among blood donors and their recipients in Iceland determined by the polymerase chain reaction (PCR). Vox Sang 1995; 69: 18–22
  • Mattson L, Sönnerborg A, Weiland O. Outcome of acute asymtomatic non-A, non-B hepatitis: a 13: year follow-up study of hepatitis C virus markers. Liver 1993; 13: 274–278
  • Norda R, Duberg A-S, Sönnerborg A, Olcén P. Transmission of hepatitis C virus by transfusion in Örebro County, Sweden, 1990–92. Scand J Infect Dis 1995; 2: 449–452
  • Reichard O, Foberg U, Frydén A, Mattson L, Norkrans G, Sönnerborg A, Wejstål R, Yun Z-B, Weiland O. High sustained response rate and clearance of viraemia with 60 weeksinterferon alfa-2b treatment for chronic hepatitis. Hepatology 1994; 19: 280–285
  • Braconier JH, Paulsen O, Engman K, Widell A. Combined alpha-interferon and Ribavirin treatment in chronic hepatitis C: A pilot study. Scand J Infect Dis 1995; 27: 325–329
  • Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88: 240–243
  • Wejstål R, Widell A, Norkrans G. Hepatitis C virus infection with progression to hepatocellular carcinoma: a report of five prospectively followed patients in Sweden. Scand J Infect Dis 1993; 25: 417–420
  • Berglund O, Beckman S, Grillner L, Jansson B, Lidbrink P, Karlsson A, Morfeldt-Månsson L, Pehrsson PO, Törngren M, Wiechel B, Åkerblom O. HIV transmission by blood transfusions in Stockholm 1979–1985: nearly uniform transmission from infected donors. AIDS 1988; 2: 51–54

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.